Stocktoria
Coloplast A/S COLO-B.CO
Coloplast A/S statistics & valuation
Multiples are price-derived and refreshed daily; everything else from the latest financial reports. The Graham number is Benjamin Graham's rough maximum fair value (kr 145.44); a green figure means the price is below it.
Profitability & efficiency
Margins and returns computed from annual filings. Falling shares outstanding = buybacks; rising = dilution. Net debt = debt − cash (negative = net cash).
P / E vs its own history
Coloplast A/S trades at about 37.2× earnings — near its 10-year norm (10-year range 33.1×–38.1×, median 38×).
Shaded band = 10-year range (33.1×–38.1×); dot = today's 37.2×.
Historical P/E = month-end price near each fiscal year-end ÷ that year's EPS. A read on whether the stock is cheap or dear relative to how it has typically been valued — not a forecast.
Key ratios (by fiscal year)
| Ratio | FY2026 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|
| Gross margin | 66.5% | 67.6% | 66.6% | 68.8% |
| Operating margin | 25.7% | 27.0% | 27.9% | 30.6% |
| Net margin | 10.6% | 18.7% | 19.5% | 20.8% |
| FCF margin | 22.2% | 5.3% | 12.2% | 17.6% |
| Return on assets | 6.6% | 10.5% | 9.9% | 12.6% |
| Return on equity | 21.5% | 28.2% | 27.6% | 56.8% |
| Debt / equity | 0.95× | 0.92× | 0.67× | 1.97× |
| Current ratio | 0.74 | 1.02 | 0.61 | 1.20 |
Computed from company filings · DK · as of 2026-09-30. Figures in DKK. Facts plus Stocktoria's own computed scores — not investment advice.